Vaccine Adjuvants Market 2019 Overview, Cost Structure Analysis, Growth Opportunities and Forecast to 2024

(The Express Wire via Comtex)

Vaccine Adjuvants Market analysis report contains all study material about Market Overview, Growth, Demand and Forecast Research in all over the world.

Global “Vaccine Adjuvants Market” report provides detail analysis of all market dynamics including drivers and restraints, and trends and opportunities. Important factors supporting growth across various is also provided. Using the industrial figures, the market finds growth figures between the forecast period from 2019 - 2024. In order to present an executive-level model of the market and its future perspectives, Vaccine Adjuvants Market report presents a clear segmentation based on different parameters. The factors that affect these segments are also discussed in detail in the report.

Following Companies Are Covered by Vaccine Adjuvants Market

  • Adjuvance
  • Adjuvatis
  • Brenntag AG
  • Chemtrade Logistics
  • GlaxoSmithKline
  • Invivogen
  • Merck KGaA
  • Novavax
  • Oz Biosciences
  • Seppic (Air Liquide)
  • Vaxliant

Get a Sample Copy of the Report -

Market Overview:

  • The propelling factors for the growth of the vaccine adjuvants market include the unmet needs for vaccines against certain diseases, expanding government recommendations for immunizations, technological innovations, and increasing use of recombinant subunit and synthetic vaccines.
  • Across the world, various governmental organizations are promoting and raising awareness regarding immunization against various diseases, like anthrax, BCG, hepatitis, HPV, influenza, varicella, smallpox, and other conditions. Thus, increasing risk of infectious diseases, effectiveness of vaccines, enhanced immunogenicity, and various government initiatives are likely to enhance the demand over the forecast period.
  • The adjuvant market is gaining a boost from the increasing use of recombinant subunit vaccines. As usage is increasing, the demand for various adjuvants is expanding. Over the coming years, more developments are expected to take place, increasing the need for adjuvants. The market is also expected to grow with a moderate rate, primarily fuelled by the increasing adoption of biologics and biosimilars and rising RandD in vaccines across the world.
  • Toxicity is the single-most crucial impediment while introducing most of the adjuvants for human use. Toxicity may also increase the financial burden on market players during the development and manufacturing phases. Thus, the negative impacts of toxicity of adjuvants on vaccine manufacturing cost and safety profiles of vaccines are hindering the growth of the market.
  • Also, there is an increasing demand for vaccine adjuvants, which is directly related to the growth of the vaccine market. Furthermore, market penetration in the case of developing countries remains low, presenting an opportunity for global vaccine adjuvant manufacturers to enter the emerging markets early and acquire sizable market shares.

Scope of the Report:

  • As per the , an adjuvant is a pharmacological or immunological agent that helps in synergizing and directing the adaptive immune response to a vaccine agent. Adjuvants are basically compounds that improve the body's immunogenic reaction against antigens. Therefore, adjuvants are majorly added to vaccines to augment their capability to persuade long-term protection and safety against any kind of infections. Vaccine adjuvants are in the method of advancement, and currently, MF59 and aluminum salts are the only adjuvants that are feasible for human usage.

The Research Document Will Answer Following Questions Such as:

What are the cutting-edge technologies responsible for driving the growth of the market?

What are the main applications of the market? What are the growth prospects to the market applications into the market?

At what stage of development are the key market products?

What are the shortcomings that has to face to become commercially viable? Is their growth and commercialization dependent on cost declines or technological/application breakthroughs?

What is the outlook for the industry?

What difference does performance characteristics of Vaccine Adjuvants create from those of established entities?

For More Information or Query or Customization before Buying, Visit at -

Key Market Trends:

Carbohydrates adjuvants is the segment under type that is expected to grow the fastest during the forecast period

Carbohydrates are easily metabolized and generate very less toxic metabolites or long-lasting tissue deposits. Due to these advantageous reasons, their acceptance and adoption have increased since its introduction in the market. Carbohydrate adjuvants with other new types have an additional role of signaling the immune system. They boost the immune response and enhance immunogenicity.

There have also been several recent developments made in the treatment of hepatitis C virus using direct acting antivirals, which has helped researchers to shorten treatment durations and minimal side effects for patients infected with HCV. A large number of research potential and possibilities are expected over the forecast period, which may be useful for better treatment of infectious diseases and cancer treatment. Thus, the growth rate is expected to be high for this type of vaccine adjuvant.

Asia-Pacific holds the fastest growth and is expected to follow the same trend over the forecast period

Asia-Pacific is expected to witness a significant growth, due to the presence of a large population prone to various chronic and infectious diseases, such as HIV, influenza, hepatitis, and cancer. Therefore, the introduction of innovative vaccine adjuvants provides better solutions to patients at marginally lower costs. The market is growing at a significant rate, owing to the development of innovative and efficient products to meet the increasing demand from end users.

Reasons for Buying Vaccine Adjuvants Market Report:

This report provides pin-point analysis for changing competitive dynamics

It provides a forward looking perspective on different factors driving or restraining market growth

It provides a five-year forecast assessed on the basis of how the market is predicted to grow

It helps in understanding the key product segments and their future

It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Purchase this Report (Price 4250 USD for single user license) -

Detailed TOC of Vaccine Adjuvants Market Report 2019-2024:

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Expanding Government Recommendations for Immunizations
4.2.2 Technological Innovations
4.2.3 Unmet Vaccine Market Needs for Certain Diseases
4.2.4 Increasing Use of Recombinant Subunit and Synthetic Vaccines
4.3 Market Restraints
4.3.1 Side Effects of Adjuvants
4.3.2 High Toxicity Adjuvants
4.3.3 High RandD Cost of Developing a New Adjuvant
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Type
5.1.1 Mineral Salt-based Adjuvant
5.1.2 Tensoactive Adjuvants
5.1.3 Adjuvant Emulsions
5.1.4 Liposome Adjuvants
5.1.5 Carbohydrate Adjuvants
5.1.6 Bacteria-derived Adjuvants
5.1.7 Organic Adjuvants
5.1.8 Virus-like Particles (VLP)
5.1.9 Other Types
5.2 By Route of Administration
5.2.1 Active Immunostimulants
5.2.2 Carriers
5.2.3 Vehicle Adjuvants
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South korea Rest of Asia-Pacific
5.3.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.3.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Adjuvance
6.1.2 Adjuvatis
6.1.3 Brenntag AG
6.1.4 Chemtrade Logistics
6.1.5 GlaxoSmithKline
6.1.6 Invivogen
6.1.7 Merck KGaA
6.1.8 Novavax
6.1.9 Oz Biosciences
6.1.10 Seppic (Air Liquide)
6.1.11 Vaxliant


Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [email protected]

For Other report :
ENT Devices Market 2019: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2024

Autonomous Vehicles Market 2019 Structure, Research Methodology, Size, Share, Forecast to 2024

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Vaccine Adjuvants Market 2019 Overview, Cost Structure Analysis, Growth Opportunities and Forecast to 2024